(MedPage Today) — Biological Psychiatry will retract a 2019 research paper on an Alzheimer’s disease treatment after an institutional investigation found research misconduct, Retraction Watch reported.
The diabetes drug empagliflozin (Jardiance…
Source link : https://www.medpagetoday.com/neurology/generalneurology/118067
Author :
Publish date : 2025-10-21 18:51:00
Copyright for syndicated content belongs to the linked Source.